Glenmark Pharmaceuticals
GLENMARK.NS
$12.68
Share price
-1.30%
Change (1 day)
84.03%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - Total assets
Total assets on the balance sheet as of September 2023 : $2.40 B
According to Glenmark Pharmaceuticals 's latest financial reports the company's total assets are $2.40 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Glenmark Pharmaceuticals - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-03-31 | $2.35 B | 4.73% |
| 2022-03-31 | $2.25 B | 6.04% |
| 2021-03-31 | $2.12 B | 9.08% |
| 2020-03-31 | $1.94 B | 1.7% |
| 2019-03-31 | $1.91 B | -4.25% |
| 2018-03-31 | $1.99 B | 6.11% |
| 2017-03-31 | $1.88 B | 15.44% |
| 2016-03-31 | $1.63 B | 5.35% |
| 2015-03-31 | $1.54 B | 7.42% |
| 2014-03-31 | $1.44 B | 9.21% |
| 2013-03-31 | $1.32 B | 14.23% |
| 2012-03-31 | $1.15 B | 1.21% |
| 2011-03-31 | $1.14 B | 4.83% |
| 2010-03-31 | $1.09 B | 30.03% |
| 2009-03-31 | $0.83 B | 13.53% |
| 2008-03-31 | $0.73 B | 64.01% |
| 2007-03-31 | $0.45 B | 48.37% |
| 2006-03-31 | $0.30 B | 44.28% |
| 2005-03-31 | $0.21 B | 100% |
| 2004-03-31 | $0.10 B |